← Eichor
Study identifier: NCT05075317 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Time Restricted Eating and Cardiac Rehabilitation

Condition: Coronary Artery Disease  ·  Sponsor: University of Toronto

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will use a form of intermittent fasting called time-restricted eating (TRE) where individuals consume ad libitum energy intake within a set window of time, commonly 8 hours, which induces a fasting window of 16 hours per day (i.e., 16:8 TRE). TRE could be an effective addition to cardiac rehabilitation as it has demonstrated cardiovascular health benefits and potential for synergy when combined with exercise training. This study will determine if TRE is a feasible and safe nutrition intervention during cardiac rehabilitation and if TRE improves the health benefits of cardiac rehabilitation compared to cardiac rehabilitation alone.

This description comes directly from the study's public registry record.

Talk to the study team

Amy Kirkham, PhD  ·  ‭(416) 946-4069‬  ·  amy.kirkham@utoronto.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Toronto Rehabilitation Institute, University Health NetworkToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05075317